Home > Resources > Videos > Does your doctor get money from drug companies?

Does your doctor get money from drug companies?

For the first time, Canadians have been given a glimpse at the millions of dollars doctors receive from pharmaceutical companies. The National is CBC Television's flagship news program. Airing seven days a week, the show delivers news, feature documentaries  and analysis from some of Canada's leading journalists.

Spotlight

Chiesi Italia

Born in Parma in 1935 as a small workshop in the province, Chiesi Farmaceutici while maintaining strong roots in Italy, it is now an international company employing over 4,500 people in 25 countries and 4 continents, 560 of which are dedicated to research and development, and has a turnover of more than € 1.46 billion. In almost 80 years of history and three generations, the company has focused its activities on the research, development, manufacturing and commercialization of therapeutic solutions, developing successful drugs distributed in over 60 countries.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now
MORE VIDEOS

Spotlight

Chiesi Italia

Born in Parma in 1935 as a small workshop in the province, Chiesi Farmaceutici while maintaining strong roots in Italy, it is now an international company employing over 4,500 people in 25 countries and 4 continents, 560 of which are dedicated to research and development, and has a turnover of more than € 1.46 billion. In almost 80 years of history and three generations, the company has focused its activities on the research, development, manufacturing and commercialization of therapeutic solutions, developing successful drugs distributed in over 60 countries.

Events